XNASTLSI
Market cap32mUSD
Jan 10, Last price
5.16USD
1D
7.95%
1Q
21.70%
IPO
-57.00%
Name
Medtech Acquisition Corp
Chart & Performance
P/E
—
P/S
8.50
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
19m
+49.31%
Net income
-59m
L+25.11%
CFO
-50m
L+54.88%
Profile
MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare sector in the United States.. The company was incorporated in 2020 and is based in Greenwich, Connecticut.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY |
|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | |
| Income | ||||
Revenues | 18,511 49.31% | 12,398 47.58% | ||
Cost of revenue | 72,661 | 48,837 | ||
Unusual Expense (Income) | ||||
NOPBT | (54,150) | (36,439) | ||
NOPBT Margin | ||||
Operating Taxes | 9 | 9 | ||
Tax Rate | ||||
NOPAT | (54,159) | (36,448) | ||
Net income | (59,038) 25.11% | (47,187) 63.59% | ||
Dividends | ||||
Dividend yield | ||||
Proceeds from repurchase of equity | 17,862 | 13,593 | ||
BB yield | -159.75% | |||
| Debt | ||||
Debt current | 351 | 370 | ||
Long-term debt | 2,839 | 3,556 | ||
Deferred revenue | ||||
Other long-term liabilities | 35,732 | 164,375 | ||
Net debt | (8,937) | (25,316) | ||
| Cash flow | ||||
Cash from operating activities | (50,045) | (32,313) | ||
CAPEX | (588) | (786) | ||
Cash from investing activities | (2,121) | (1,786) | ||
Cash from financing activities | 54,629 | 13,462 | ||
FCF | (73,155) | (18,925) | ||
| Balance | ||||
Cash | 11,777 | 9,414 | ||
Long term investments | 350 | 19,828 | ||
Excess cash | 11,201 | 28,622 | ||
Stockholders' equity | (248,375) | (186,344) | ||
Invested Capital | 259,764 | 176,325 | ||
ROIC | ||||
ROCE | 363.70% | |||
| EV | ||||
Common stock shares outstanding | 9,396 | 29,608 | ||
Price | 1.19 | |||
Market cap | 11,181 | |||
EV | 2,244 | |||
EBITDA | (53,448) | (36,041) | ||
EV/EBITDA | ||||
Interest | 16 | 1,000 | ||
Interest/NOPBT | ||||